Purpose of review: Traumatic optic neuropathy is common clinical problem for neuro-ophthalmologists, without evidence-based guidelines regarding evaluation and therapy. Although no large natural history or randomized controlled trial has been published, corticosteroid therapy, surgical decompression or observation remains the mainstays of therapy.
Recent findings: Additional research is ongoing, concerning medications and therapies to enhance visual recovery following trauma; future treatments may concern neuroprotective factors and retinal ganglion cell regeneration.
Summary: A randomized control trial would likely provide the best understanding of the disease as well as reliable treatment guide.